X-Lab Solutions SRL

Type of financial statements
Balance Sheet	RON
Fixed assets - TOTAL	5,326,698
Current assets - TOTAL, of which	5,093,897
Inventories (materials, production in progress, semi-finished products, goods, etc..)	2,597,045
Receivables	2,415,945
Cash on hand and bank accounts	80,907
PREPAID EXPENSES	-
DEBTS - TOTAL	7,567,051
DEFERRED INCOME	-
PROVISIONS	-
Capital - TOTAL, of which	2,853,544
Paid-in capital	200
PROFIT AND LOSS
Annual turnover	10,828,070
Total revenues	11,055,629
Total expenses	10,598,733
Profit or loss before tax
-Profit	456,896
-Loss	0
Net profit or loss
-Profit	456,896
-Loss	0
INFORMATIVE DATA
No of employees	21
Main activity, according to CAEN	Retail of pharmaceutical products

Type of financial statements
Balance Sheet	RON
Fixed assets - TOTAL	5,827,857
Current assets - TOTAL, of which	5,575,828
Inventories (materials, production in progress, semi-finished products, goods, etc..)	2,063,613
Receivables	3,508,694
Cash on hand and bank accounts	3,521
PREPAID EXPENSES	-
DEBTS - TOTAL	9,007,037
DEFERRED INCOME	-
PROVISIONS	-
Capital - TOTAL, of which	2,396,648
Paid-in capital	200
PROFIT AND LOSS
Annual turnover	10,352,144
Total revenues	10,662,701
Total expenses	11,376,020
Profit or loss before tax
-Profit	0
-Loss	713,319
Net profit or loss
-Profit	0
-Loss	713,319
INFORMATIVE DATA
No of employees	20
Main activity, according to CAEN	Retail of pharmaceutical products

Type of financial statements
Balance Sheet	RON
Fixed assets - TOTAL	6,038,419
Current assets - TOTAL, of which	5,438,745
Inventories (materials, production in progress, semi-finished products, goods, etc..)	2,485,880
Receivables	2,719,221
Cash on hand and bank accounts	233,644
PREPAID EXPENSES	-
DEBTS - TOTAL	8,367,197
DEFERRED INCOME	-
PROVISIONS	-
Capital - TOTAL, of which	3,109,967
Paid-in capital	200
PROFIT AND LOSS
Annual turnover	11,208,289
Total revenues	11,759,633
Total expenses	12,410,572
Profit or loss before tax
-Profit	0
-Loss	650,939
Net profit or loss
-Profit	0
-Loss	672,368
INFORMATIVE DATA
No of employees	21
Main activity, according to CAEN	Retail of pharmaceutical products

Type of financial statements
Balance Sheet	RON
Fixed assets - TOTAL	7,898,630
Current assets - TOTAL, of which	4,281,798
Inventories (materials, production in progress, semi-finished products, goods, etc..)	2,181,017
Receivables	2,015,716
Cash on hand and bank accounts	85,065
PREPAID EXPENSES	390,934
DEBTS - TOTAL	7,854,640
DEFERRED INCOME	-
PROVISIONS	-
Capital - TOTAL, of which	4,716,722
Paid-in capital	200
PROFIT AND LOSS
Annual turnover	9,758,633
Total revenues	12,039,465
Total expenses	11,736,516
Profit or loss before tax
-Profit	302,949
-Loss	0
Net profit or loss
-Profit	229,840
-Loss	0
INFORMATIVE DATA
No of employees	23
Main activity, according to CAEN	Retail of pharmaceutical products

Type of financial statements	BALANCE ACCORDING TO ORDER 1752/2005
Balance Sheet	RON
Fixed assets - TOTAL	9,869,407
Current assets - TOTAL, of which	5,935,033
Inventories (materials, production in progress, semi-finished products, goods, etc..)	1,830,295
Receivables	3,311,786
Cash on hand and bank accounts	792,952
PREPAID EXPENSES	-
DEBTS - TOTAL	11,317,559
DEFERRED INCOME	-
PROVISIONS	-
Capital - TOTAL, of which	4,486,881
Paid-in capital	200
PROFIT AND LOSS
Annual turnover	17,645,427
Total revenues	18,616,014
Total expenses	18,048,138
Profit or loss before tax
-Profit	567,876
-Loss	-
Net profit or loss
-Profit	472,266
-Loss	-
INFORMATIVE DATA
No of employees	26
Main activity, according to CAEN	Retail of pharmaceutical products

Type of financial statements	BALANCE ACCORDING TO ORDER 1752/2005
Balance Sheet	RON
Fixed assets - TOTAL	9,781,290
Current assets - TOTAL, of which	5,601,381
Inventories (materials, production in progress, semi-finished products, goods, etc..)	4,093,751
Receivables	1,426,969
Cash on hand and bank accounts	80,661
PREPAID EXPENSES	-
DEBTS - TOTAL	10,980,097
DEFERRED INCOME	-
PROVISIONS	-
Capital - TOTAL, of which	4,402,574
Paid-in capital	200
PROFIT AND LOSS
Annual turnover	11,032,075
Total revenues	11,777,055
Total expenses	11,662,555
Profit or loss before tax
-Profit	114,500
-Loss	-
Net profit or loss
-Profit	69,466
-Loss	-
INFORMATIVE DATA
No of employees	27
Main activity, according to CAEN	Retail of pharmaceutical products

Type of financial statements	BALANCE ACCORDING TO ORDER 1752/2005
Balance Sheet	RON
Fixed assets - TOTAL	6,073,233
Current assets - TOTAL, of which	7,206,985
Inventories (materials, production in progress, semi-finished products, goods, etc..)	4,644,812
Receivables	2,003,982
Cash on hand and bank accounts	558,191
PREPAID EXPENSES	116,977
DEBTS - TOTAL	8,292,849
DEFERRED INCOME	-
PROVISIONS	-
Capital - TOTAL, of which	5,104,346
Paid-in capital	200
PROFIT AND LOSS
Annual turnover	49,845,546
Total revenues	50,203,543
Total expenses	48,474,854
Profit or loss before tax
-Profit	1,728,689
-Loss	-
Net profit or loss
-Profit	1,461,725
-Loss	-
INFORMATIVE DATA
No of employees	26
Main activity, according to CAEN	Retail of pharmaceutical products

Type of financial statements	BALANCE ACCORDING TO ORDER 1752/2005
Balance Sheet	RON
Fixed assets - TOTAL	3,677,943
Current assets - TOTAL, of which	17,846,127
Inventories (materials, production in progress, semi-finished products, goods, etc..)	8,907,373
Cash and deposits	1,301,787
Receivables	7,636,967
Capital - TOTAL, of which	4,276,572
Paid-in capital	200
Provisions for risks and charges	-
Total debt	17,247,498
PROFIT AND LOSS
Annual turnover	17,226,697
Total revenues	17,382,632
Total expenses	15,543,104
Profit before tax	1,839,528
Loss before tax	-
Net profit	1,544,080
Net loss	-
INFORMATIVE DATA
No of employees	18
Main activity, according to CAEN	Retail of pharmaceutical products

Type of financial statements	BALANCE ACCORDING TO ORDER 1752/2005
Balance Sheet	RON
Fixed assets - TOTAL	2,195,851
Current assets - TOTAL, of which	3,025,162
Inventories (materials, production in progress, semi-finished products, goods, etc..)	1,147,893
Cash and deposits	717,575
Receivables	1,159,694
Capital - TOTAL, of which	1,126,064
Paid-in capital	200
Provisions for risks and charges	-
Total debt	4,324,220
PROFIT AND LOSS
Annual turnover	8,629,072
Total revenues	8,943,688
Total expenses	8,005,211
Profit before tax	938,477
Loss before tax	-
Net profit	800,625
Net loss	-
INFORMATIVE DATA
No of employees	15
Main activity, according to CAEN	Retail of pharmaceutical products

Type of financial statements	SIMPLIFIED
Balance Sheet	RON
Fixed assets - TOTAL	1,367,668
Current assets - TOTAL, of which	2,530,986
Inventories (materials, production in progress, semi-finished products, goods, etc..)	789,862
Cash and deposits	879,259
Receivables	861,865
ron	1,004,392
Paid-in capital	200
Provisions for risks and charges	0
Total debt	3,034,850
Profit and Loss
Annual turnover	5,407,778
Total revenues	5,554,936
Total expenses	4,944,166
Profit before tax	610,770
Loss before tax	0
Net profit	514,980
Net loss	0
Informative data
No of employees	12
Main activity, according to CAEN	Retail of pharmaceutical products

Type of financial statements	SIMPLIFIED
Balance Sheet	RON
Fixed assets - TOTAL	7,466,018
Current assets - TOTAL, of which	15,574,070
Inventories (materials, production in progress, semi-finished products, goods, etc..)	7,721,490
Cash and deposits	2,143,317
Receivables	5,709,263
Capital - TOTAL, of which	4,894,119
Paid-in capital	2,000
Provisions for risks and charges	-
Total debt	16,169,313
PROFIT AND LOSS
Annual turnover	40,502,476
Total revenues	41,170,643
Total expenses	35,589,453
Profit before tax	5,581,190
Loss before tax	-
Net profit	4,229,422
Net loss	-
INFORMATIVE DATA
No of employees	10
Main activity, according to CAEN	Retail of pharmaceutical products

Type of financial statements	SIMPLIFIED
Balance Sheet	RON
Total fixed assets	1,106,083
Current assets - TOTAL, of which	10,317,227
Inventories (materials, production in progress, semi-finished products, goods, etc..)	4,180,385
Cash and deposits	2,483,182
Receivables	3,653,660
Capital - TOTAL, of which	664,692
Paid-in capital	2,000
Provisions for risks and charges	-
Total debt	10,957,007
PROFIT AND LOSS
Annual turnover	16,507,299
Total revenues	16,592,602
Total expenses	16,322,512
Profit before tax	270,090
Loss before tax	-
Net profit	178,503
Net loss	-
INFORMATIVE DATA
No of employees	7
Main activity, according to CAEN	Retail of pharmaceutical products

Type of financial statements	SIMPLIFIED
Balance Sheet	RON
Total fixed assets	1,066,126
Current assets - TOTAL, of which	6,596,570
Inventories (materials, production in progress, semi-finished products, goods, etc..)	2,009,940
Cash and deposits	506,786
Clients and related accounts	3,193,346
Other receivables	1,776,387
Capital - TOTAL, of which	486,194
Paid-in capital	2,000
Provisions for risks and charges	263,502
Total debt	7,934,715
PROFIT AND LOSS
Annual turnover	7,071,018
Total revenues	7,307,369
Total expenses	6,584,096
Profit before tax	723,273
Loss before tax	-
Net profit	484,194
Net loss	-
INFORMATIVE DATA
No of employees	4
Main activity, according to CAEN	Retail, not in stores

X-lab Solutions - Pursuing the excellence

Financial status

Financial status